Jason Derrick Watkins

Title: Jason Derrick Watkins: Innovator in Nucleic Acid Binding Assays

Introduction

Jason Derrick Watkins is a notable inventor based in Greenville, SC (US). He has made significant contributions to the field of nucleic acid binding assays, holding a total of 3 patents. His work focuses on developing small molecule fluorescent probes that target nucleic acids, including DNA and RNA.

Latest Patents

Watkins' latest patents involve methods and compositions related to nucleic acid binding assays. These small molecule fluorescent probes are designed for established drug targets such as nucleic acids. The probes bind to various DNA and RNA structures, specifically targeting crucial sites for nucleic acid function, including the major grooves of DNA and RNA. When displaced by other binders, such as small molecule compounds or proteins, the probes exhibit a fluorescence change. This change can be detected and analyzed to provide binding information about these other compounds of interest. Additionally, the fluorescence changes upon binding of the probes to nucleic acids have been utilized to screen nucleic acids of different sequences and conformations. The nucleic acid probes and methods disclosed are particularly suitable for high-throughput screening of libraries of small molecule compounds, proteins, and nucleic acids.

Career Highlights

Watkins is currently associated with Nubad, LLC, where he continues to innovate in the field of nucleic acid research. His work has the potential to advance drug discovery and development significantly.

Collaborations

Some of his notable coworkers include Dev P Arya and Frank Anderson Norris, who contribute to the collaborative efforts at Nubad, LLC.

Conclusion

Jason Derrick Watkins is a prominent inventor whose work in nucleic acid binding assays is paving the way for advancements in drug discovery. His innovative approaches and collaborations are making a significant impact in the field.